Ardena Signs Agreement to Expand US Footprint with the …
5 days ago · Ghent, Belgium, 14 th October 2024. Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey.
Ardena Signs Agreement to Expand US Footprint with the …
4 days ago · Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical ...
Catalent sells New Jersey production plant, HQ to Belgium's Ardena
4 days ago · Catalent is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey, to Belgium’s Ardena for an undisclosed sum. The transaction is expected to close ...
Ardena Signs Agreement to Expand US Footprint with the
4 days ago · Follow. Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the ...
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
5 days ago · Oct 14, 2024 – Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that it has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset, NJ to Ardena, a Contract Development and Manufacturing Organization (CDMO) with locations in Belgium ...
Ardena announces key leadership changes to drive growth and ...
Jul 16, 2024 · Ariane De Ganck, based in Ghent, Belgium, has been promoted to Division Head, Drug Product Services. Ariane will report directly to Ardena’s CEO, Jeremie Trochu, a change that underscores her exceptional leadership and significant …
Ardena appoints Jeremie Trochu as Chief Executive Officer
Ghent, Belgium – Ardena (the “Company”) today announces the retirement of Harry Christiaens, PhD and the subsequent appointment of Jeremie Trochu as Chief Executive Officer. Jeremie is a seasoned executive in the pharmaceutical Contract Development and Manufacturing Operations (CDMO) industry.
Catalent to sell New Jersey facility - MSN
Catalent and Ardena did not disclose financial terms of the deal, which is expected to close in early 2025. Ardena, a provider of drug development services, said the facility will help boost its ...
Catalent to sell New Jersey facility | Reuters
4 days ago · Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on Monday.
Ardena appoints Jeremie Trochu as Chief Executive Officer - PR …
GHENT, Belgium, June 6, 2024 /PRNewswire/ -- Ardena (the "Company") today announces the retirement of Harry Christiaens, PhD and the subsequent appointment of Jeremie Trochu as Chief Executive...